AngioDynamics ANGO Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $78.42M+8.9% | $79.43M+9.0% | $75.71M+12.2% | $80.16M+12.9% | $72M-4.2% | ||
| $36.94M+11.5% | $34.65M+5.2% | $33.85M+10.0% | $37.94M+16.9% | $33.15M-15.7% | ||
| $41.48M+6.7% | $44.78M+12.2% | $41.86M+14.0% | $42.22M+9.6% | $38.86M+8.4% | ||
| 52.9%-1.1pp | 56.4%+1.6pp | 55.3%+0.9pp | 52.7%-1.6pp | 54%+6.3pp | ||
| $7.08M+2.5% | $7.77M+20.7% | $6.42M+2.1% | $6.59M-2.0% | $6.91M-15.6% | ||
| $27.44M+7.6% | $26.71M+4.4% | $28.13M+9.9% | $26.44M+7.6% | $25.5M+0.4% | ||
| $10.72M+2.2% | $10.15M-2.3% | $12.56M+14.4% | $10.24M-2.0% | $10.49M-0.8% | ||
| $54.43M+11.5% | $50.91M-0.2% | $52.51M+5.4% | $48.01M-9.4% | $48.83M-79.9% | ||
| -$12.95M-29.8% | -$6.13M+44.8% | -$10.66M+18.6% | -$5.79M+59.9% | -$9.97M+95.0% | ||
| -16.5%-2.7pp | -7.7%+7.5pp | -14.1%+5.3pp | -7.2%+13.1pp | -13.9%+252pp | ||
| -$88K-165% | -$102K-144% | -$4K-101% | $3K+101% | $135K+134% | ||
| $4.88M-12.3% | -$230K-193% | -$182K-142% | —— | $5.57M+3,467% | ||
| -$8.07M-83.1% | -$6.36M+41.4% | -$10.84M+14.4% | -$6.11M+56.8% | -$4.41M+97.8% | ||
| $12K+700% | -$5K+95.5% | $65K-51.1% | -$60K+91.3% | -$2K+100.0% | ||
| -$8.08M-83.4% | -$6.35M+40.9% | -$10.9M+14.8% | -$6.05M+55.0% | -$4.41M+97.7% | ||
| -10.3%-4.2pp | -8%+6.7pp | -14.4%+4.6pp | -7.5%+11.4pp | -6.1%+244pp | ||
| -$0.19-72.7% | -$0.15+42.3% | -$0.26+16.1% | -$0.15+54.5% | -$0.11+97.6% | ||
| -$7.36M-101% | -$378K+91.1% | -$4.64M+26.6% | $45K+101% | -$3.66M+98.1% | ||
| -9.4%-4.3pp | -0.5%+5.3pp | -6.1%+3.2pp | 0.1%+10.8pp | -5.1%+251pp | ||
| -$12.95M-29.8% | -$6.13M+44.8% | -$10.66M+18.6% | -$5.79M+59.9% | -$9.97M+95.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is AngioDynamics's revenue?
- AngioDynamics (ANGO) generated $313.7M in revenue over the trailing twelve months, up 10.7% year over year.
- Is AngioDynamics profitable?
- AngioDynamics is not currently profitable: it reported a net loss of $31.4M over the trailing twelve months, a -10.0% net margin.
- What are AngioDynamics's profit margins?
- Gross margin is 54.3% and operating margin is -11.3%, with a -10.0% net margin.
- What is AngioDynamics's earnings per share?
- AngioDynamics's diluted EPS over the trailing twelve months is $-0.75.
- Where does AngioDynamics's income statement data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
